Midol Complete ACETAMINOPHEN, CAFFEINE, and PYRILAMINE MALEATE 500 mg; 60 mg; 15 mg Tablet, 4-count
by Select Consumer Group · 2 POUCH in 1 BLISTER PACK (85237-1841-2) / 2 TABLET in 1 POUCH
NDC 85237-1841-02
🏷️ FDA NDC (as labeled)
85237-1841-2
billing pads the package segment with a zero
This package
Contains4-count
Pack sizes5 compare ↓
Also comes in:
2 tablets 85237-1841-01
40 tablets 85237-1841-03
50 tablets 85237-1841-04
60 tablets 85237-1841-05
OTC
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
85237-1841-2
Product NDC
85237-1841
11-digit billing NDC
85237184102
RxCUI
1597298
UNII
362O9ITL9D, 3G6A5W338E, R35D29L3ZA
UPC
0655708118412
Application #
M027
SPL Set ID
3ca96ed9-d9af-dbfe-e063-6394a90a2932
Established class (EPC)
Central Nervous System Stimulant; Methylxanthine
Physiologic effect
Central Nervous System Stimulation
Chemical class
Xanthines
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2014-02-10
Route
ORAL
Dosage form
TABLET
Substance
ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE
Why two NDCs?
The FDA registers this code as 85237-1841-2 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 85237-1841-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Anilides class.
Drug family (ATC)
Anilides
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerSelect Consumer Group
FDA applicationM027 (OTC MONOGRAPH DRUG)
Labeler code85237
First marketedFeb 2014
Product typeHuman Otc Drug
Portfolio21 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
🧪 What is this product?
Midol Complete is an over-the-counter oral tablet containing three active ingredients. Acetaminophen is a pain reliever and fever reducer. Caffeine is a stimulant typically included to enhance the pain-relieving effects and increase alertness. Pyrilamine maleate is an antihistamine commonly used to reduce drowsiness and provide mild sedation relief. This product is marketed as an OTC monograph drug, meaning it follows established FDA guidelines for its category rather than undergoing individual application review.
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about ACETAMINOPHEN, CAFFEINE, and PYRILAMINE MALEATE?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Midol Complete 500 mg/1; 60 mg/1; 15 mg 00280-8005-16 | Bayer | 16 tablets | — | — | FDA listed | — |
| Midol Complete Gelcaps 60 mg/1; 15 mg/1; 500 mg 00280-8015-24 | Bayer | 24 tablets | — | — | FDA listed | — |
| Menstrual Relief Maximum Strength 500 mg/1; 60 mg/1; 15 mg 00363-0252-21 | Walgreen | 8 tablets | — | — | FDA listed | — |
| Acetaminophen 500mg Caffeine 60mg Pyrilamine maleate 15mg 500 mg/1; 60 mg/1; 15 mg 00363-2310-24 | WALGREENS | 24 tablets | — | — | FDA listed | — |
| Menstrual Pain Relief 500 mg/1; 60 mg/1; 15 mg 00363-3900-10 | Walgreen | 40 tablets | — | — | Discontinued | — |
| Menstrual Relief 500 mg/1; 60 mg/1; 15 mg 00363-3909-21 | Walgreen | 8 tablets | — | — | FDA listed | — |
| Menstrual Complete Pain Relief 500 mg/1; 60 mg/1; 15 mg 00363-9390-10 | Walgreen | 40 tablets | — | — | FDA listed | — |
| Midol Complete 500 mg/1; 60 mg/1; 15 mg 00924-6010-02 | Acme | 100 tablets | — | — | FDA listed | — |
| Multi-Symptom Menstrual Relief 500 mg/1; 60 mg/1; 15 mg 11673-0363-64 | TARGET | 40 tablets | — | — | FDA listed | — |
| Menstrual Relief 500 mg/1; 60 mg/1; 15 mg 11673-0390-10 | Target | 40 tablets | — | — | FDA listed | — |
| Menstrual Complete Maximum Strength 500 mg/1; 60 mg/1; 15 mg 11822-0390-01 | Rite | 40 tablets | — | — | FDA listed | — |
| Menstrual Complete 500 mg/1; 60 mg/1; 15 mg 11822-3900-01 | Rite | 40 tablets | — | — | FDA listed | — |
| Menstrual Relief 500 mg/1; 60 mg/1; 15 mg 21130-0930-10 | Better | 40 tablets | — | — | FDA listed | — |
| Midol Complete 500 mg/1; 60 mg/1; 15 mg 29485-7964-02 | Lil' | 50 tablets | — | — | FDA listed | — |
| Menstrual Complete 500 mg/1; 60 mg/1; 15 mg 30142-0390-10 | Kroger | 40 tablets | — | — | FDA listed | — |
| Menstrual Complete 500 mg/1; 60 mg/1; 15 mg 36800-0391-08 | Topco | 24 tablets | — | — | FDA listed | — |
| Menstrual Complete 500 mg/1; 60 mg/1; 15 mg 37808-0389-10 | H | 40 tablets | — | — | FDA listed | — |
| Menstrual Relief Maximum Strength 500 mg/1; 60 mg/1; 15 mg 41163-0390-10 | United | 40 tablets | — | — | FDA listed | — |
| Menstrual Relief 500 mg/1; 60 mg/1; 15 mg 41163-0391-10 | United | 40 tablets | — | — | FDA listed | — |
| Comfort-Time 500 mg/1; 60 mg/1; 15 mg 49483-0347-24 | Time | 24 tablets | — | — | FDA listed | — |
| Midol Complete 500 mg/1; 60 mg/1; 15 mg 50269-0007-06 | JC | 12 tablets | — | — | FDA listed | — |
| Midol Complete 500 mg/1; 60 mg/1; 15 mg 50269-0009-06 | JC | 24 tablets | — | — | FDA listed | — |
| Menstrual Relief 500 mg/1; 60 mg/1; 15 mg 50804-0990-08 | Geiss, | 24 tablets | — | — | FDA listed | — |
| Menstrual Complete Maximum Strength 500 mg/1; 60 mg/1; 15 mg 50844-0390-19 | L.N.K. | 8 tablets | — | — | FDA listed | — |
| Menstrual Complete 500 mg/1; 60 mg/1; 15 mg 50844-0399-08 | L.N.K. | 24 tablets | — | — | FDA listed | — |
| Menstrual Relief 500 mg/1; 60 mg/1; 15 mg 51316-0390-10 | CVS | 40 tablets | — | — | FDA listed | — |
| Menstrual Complete 500 mg/1; 60 mg/1; 15 mg 53943-0390-10 | Discount | 40 tablets | — | — | FDA listed | — |
| Menstrual Complete 500 mg/1; 60 mg/1; 15 mg 55319-0301-21 | Family | 8 tablets | — | — | FDA listed | — |
| Dolex Fem 500 mg/1; 60 mg/1; 15 mg 55758-0326-25 | Pharmadel | 24 tablets | — | — | FDA listed | — |
| Menstrual Relief 500 mg/1; 60 mg/1; 15 mg 55910-0123-10 | DOLGENCORP, | 40 tablets | — | — | FDA listed | — |
| Menstrual Relief 500 mg/1; 60 mg/1; 15 mg 59779-0930-08 | CVS | 8 tablets | — | — | FDA listed | — |
| Menstrual Complete Maximum Strength 500 mg/1; 60 mg/1; 15 mg 63868-0032-24 | CHAIN | 24 tablets | — | — | FDA listed | — |
| Midol Complete, Travel BASIX 500 mg/1; 60 mg/1; 15 mg 66715-6445-02 | Lil' | 4 tablets | — | — | FDA listed | — |
| Midol Complete 500 mg/1; 60 mg/1; 15 mg 66715-9745-02 | Lil' | 4 tablets | — | — | FDA listed | — |
| Menstrual Complete 500 mg/1; 60 mg/1; 15 mg 67091-0334-40 | WinCo | 40 tablets | — | — | FDA listed | — |
| Midol 500 mg/1; 60 mg/1; 15 mg 67751-0145-01 | Navajo | 4 tablets | — | — | FDA listed | — |
| Menstrual Complete 500 mg/1; 60 mg/1; 15 mg 69168-0470-06 | Allegiant | 120 tablets | — | — | FDA listed | — |
| Menstrual Complete 500 mg/1; 60 mg/1; 15 mg 69517-0130-20 | Healthlife | 20 tablets | — | — | FDA listed | — |
| Buscapina 500 mg/1; 60 mg/1; 15 mg 69729-0130-24 | OPMX | 24 tablets | — | — | FDA listed | — |
| Buscapina 500 mg/1; 60 mg/1; 15 mg 69729-0131-72 | OPMX | 2 tablets | — | — | FDA listed | — |
| Buscapina 15 mg/1; 500 mg/1; 60 mg 69729-0132-06 | OPMX | 2 tablets | — | — | FDA listed | — |
| Buscapina 15 mg/1; 500 mg/1; 60 mg 69729-0818-50 | OPMX | 2 tablets | — | — | FDA listed | — |
| Midol Complete 15 mg/1; 500 mg/1; 60 mg 70264-0012-01 | R | 100 tablets | — | — | FDA listed | — |
| Menstrual Complete 500 mg/1; 60 mg/1; 15 mg 70692-0131-24 | Strive | 24 tablets | — | — | FDA listed | — |
| Menstrual Complete 60 mg/1; 15 mg/1; 500 mg 72090-0026-02 | Pioneer | 40 tablets | — | — | FDA listed | — |
| Menstrual Complete 500 mg/1; 60 mg/1; 15 mg 79481-0390-01 | Meijer | 40 tablets | — | — | FDA listed | — |
| Menstrual Complete 500 mg/1; 60 mg/1; 15 mg 79903-0266-40 | WALMART | 40 tablets | — | — | FDA listed | — |
| FLO PMS Complete 500 mg/1; 60 mg/1; 15 mg 83049-0489-08 | O | 24 tablets | — | — | FDA listed | — |
| Menstrual Pain Relief Complete 500 mg/1; 60 mg/1; 15 mg 83059-0006-01 | Shield | 15 tablets | — | — | Discontinued | — |
| Menstrual Pain Relief Complete 500 mg/1; 60 mg/1; 15 mg 83059-0105-01 | Shield | 15 tablets | — | — | FDA listed | — |
| Menstrual Pain Relief Complete 500 mg/1; 60 mg/1; 15 mg 83059-0119-08 | Shield | 80 tablets | — | — | FDA listed | — |
| Menstrual Complete 500 mg/1; 60 mg/1; 15 mg 83324-0017-24 | Chain | 24 tablets | — | — | FDA listed | — |
| Syncol Max 500 mg/1; 60 mg/1; 15 mg 83393-0390-02 | Laboratorios | 12 tablets | — | — | FDA listed | — |
| Midol Complete 500 mg/1; 60 mg/1; 15 mgthis 85237-1841-02 | Select | 4 tablets | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2014
On the market since
Feb 2014
📍
2026
Currently FDA-listed
12 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Midol Complete (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 3%
Female · 97%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 85237-1841-01 | 1 POUCH in 1 BLISTER PACK (85237-1841-1) / 2 TABLET in 1 POUCH | 2014-02-10 | Active |
| 85237-1841-02 You're viewing this | 2 POUCH in 1 BLISTER PACK (85237-1841-2) / 2 TABLET in 1 POUCH | 2014-02-10 | Active |
| 85237-1841-03 | 20 POUCH in 1 BOX, UNIT-DOSE (85237-1841-3) / 2 TABLET in 1 POUCH | 2014-02-10 | Active |
| 85237-1841-04 | 25 POUCH in 1 BOX, UNIT-DOSE (85237-1841-4) / 2 TABLET in 1 POUCH | 2014-02-10 | Active |
| 85237-1841-05 | 30 POUCH in 1 BOX, UNIT-DOSE (85237-1841-5) / 2 TABLET in 1 POUCH | 2014-02-10 | Active |
Pack size FAQ
What quantity is in NDC 85237-1841-02?
NDC 85237-1841-02 is a 4-count package — 2 pouch in 1 blister pack / 2 tablet in 1 pouch.
What is the difference between NDC 85237-1841-02 and NDC 85237-1841-01?
Both are Midol Complete ACETAMINOPHEN, CAFFEINE, and PYRILAMINE MALEATE 500 mg; 60 mg; 15 mg Tablet — the drug itself is identical. NDC 85237-1841-02 is the 4-count package, while NDC 85237-1841-01 is the 2 tablets package.
What NDC number is used to bill for this package of Midol Complete ACETAMINOPHEN, CAFFEINE, and PYRILAMINE MALEATE 500 mg; 60 mg; 15 mg Tablet?
Bill NDC 85237-1841-02 — the 11-digit billing format is 85237184102. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 85237-1841-2, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 85237-1841-02, written without dashes as 85237184102. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 85237-1841-02, the first segment (85237) is the labeler code FDA assigned to Select Consumer Group; the middle segment (1841) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (02) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Select Consumer Group. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 4 other package presentations of this same product, including 2 tablets (85237-1841-01), 40 tablets (85237-1841-03), 50 tablets (85237-1841-04). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Select Consumer Group is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses for the temporary relief of these symptoms associated with menstrual periods: cramps bloating water-weight gain headache backache muscle aches fatigue
⏱️ Dosage and Administration ▾
Directions do not take more than the recommended dose adults and children 12 years and older: take 2 caplets with water repeat every 6 hours, as needed do not exceed 6 caplets per day children under 12 years: consult a doctor
⚠️ Warnings ▾
Warnings Liver warning This product contains acetaminophen. Severe liver damage may occur if you take more than 6 caplets in 24 hours, which is the maximum daily amount for this product with other drugs containing acetaminophen 3 or more alcoholic drinks every day while using this product Do not use with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. if you have ever had an allergic reaction to this product or any of its ingredients Ask a doctor before use if you have liver disease glaucoma difficulty in urination due to enlargement of the prostate gland a breathing problem such as emphysema or chronic bronchitis Ask a doctor or pharmacist before use if you are taking the blood thinning drug warfarin taking sedatives or tranquilizers When using this product you may get drowsy avoid alcoholic drinks excitability may occur, especially in children alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving a motor vehicle or operating machinery limit the use of caffeine-containing medications, foods, or beverages because too much caffeine may cause nervousness, irritability, sleeplessness, and, occasionally, rapid heartbeat.
The recommended dose of this product contains about as much caffeine as a cup of coffee. Stop use and ask a doctor if new symptoms occur redness or swelling is present pain gets worse or lasts more than 10 days fever gets worse or lasts more than 3 days If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away. Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
📦 Storage and Handling ▾
Other information store at room temperature
🧪 Active Ingredient ▾
Active ingredients (in each caplet) Purpose Acetaminophen 500 mg Pain reliever Caffeine 60 mg Diuretic Pyrilamine maleate 15 mg Antihistamine
🧪 Inactive Ingredients ▾
Inactive ingredients carnauba wax, croscarmellose sodium, FD&C blue #2 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, pregelatinized starch, propylene glycol, shellac, titanium dioxide, triacetin
🎯 Purpose ▾
Active ingredients (in each caplet) Purpose Acetaminophen 500 mg Pain reliever Caffeine 60 mg Diuretic Pyrilamine maleate 15 mg Antihistamine
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.